InflammoPharmacology is the official publication of the Gastrointestinal Section of the International Union of Pharmacology (IUPHAR) and the Hungarian Society for Experimental and clinical Pharmacology (HSECP). InflammoPharmacology publishes papers on all aspects of inflammation and its pharmacological control emphasizing comparisons of (a) different inflammatory states, and (b) the actions, therapeutic efficacy and safety of drugs employed in the treatment of inflammatory conditions. The comparative aspects of the types of inflammatory conditions include gastrointestinal disease (e.g. ulcerative colitis, Crohn"s disease), parasitic diseases, toxicological manifestations of the effects of drugs and environmental agents, and arthritic conditions.
| YEAR | Impact Factor |
|---|---|
| 2024-25 | 5.3 |
| 2023 | 4.6 |
| 2022 | 5.8 |
| 2021 | 5.093 |
INFLAMMOPHARMACOLOGY, 0925-4692, SPRINGER BASEL AG, Immunology and Microbiology,Medicine,Pharmacology, Toxicology and Pharmaceutics.